This episode is brought to you by the letter p
What does the p-value actually mean? Read More...
Beta-alanine revisited: Failing to plan, or planning to fail?
In the past 2.5 years, a few more studies on beta-alanine have emerged. As I’ve written before, my goal isn’t to become the anti-beta-alanine blogger, but I do feel that watching this supplement develop from its relative inception to its current state does provide an interesting prototype for how similar products develop a strong following despite the limitations on the research available to support (or not support) its use. Read More...
You don’t always get what you want, even if you get what you need
One of the newer supplements on the market are the aromatase inhibitors. They purport to increase free testosterone levels by inhibiting the enzyme that is responsible for converting androstenedione to estrone as well as converting testosterone to estradiol. By preventing the breakdown of testosterone precursors and the breakdown of testosterone itself, the concentration of testosterone should theoretically increase. Read More...
HIIT vs Steady State–Again.
Thanks to Mike Knowles who suggested this week’s study (which, incidentally, was incorrectly cited in that publication you sent me, but that’s not your fault 🙂 ). Read More...
Different kinds of important.
In clinical research, there are two kinds of important–the important kind and the unimportant kind. Read More...